Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...

Rheumatic Heart Disease I: Introduction

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...

Hypersensitivity Reactions: Immune-Complex Reactions

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A three-year randomized, double-blind, placebo-controlled study of lanreotide in stage 2/3 autosomal dominant polycystic kidney disease.

Kidney international·2026

Same author

Copeptin is a reliable biomarker of vasopressin and is associated with urine osmolality in patients on peritoneal dialysis.

Journal of nephrology·2026

Same author

Identifying distinct clinical phenotypes and outcomes in adult-onset IgA vasculitis using unsupervised clustering analysis.

European journal of internal medicine·2026

Same author

A Pathway to High Quality Clinical Trials in IgA Vasculitis Nephritis: Meeting Proceedings From a Multiprofessional International Collaborative Workshop.

Kidney international reports·2026

Same author

Clinicopathological Spectrum and Treatment Outcomes of Cryofibrinogen-Associated Nephropathies.

Kidney international reports·2026

Same author

Effect of Baseline Dialysis and Plasma Exchange on Renal Prognosis in Patients With Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.

Kidney international reports·2025

Search research articles

Related Experiment Video

Updated: Jun 24, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

[Henoch-Shönlein purpura].

Evangeline Pillebout¹, Dominique Nochy, Eric Thervet

¹Service de néphrologie et transplantation rénale, hôpital Saint-Louis, Paris, France. evangeline.pillebout@sls.aphp.fr

Nephrologie & Therapeutique

|April 7, 2009

Summary

Henoch-Shönlein purpura (HSP), an IgA vasculitis, affects small vessels and can lead to nephritis. While often mild in children, HSP can be severe in adults, with renal failure a significant long-term risk.

Area of Science:

Immunology
Rheumatology
Nephrology

Background:

Henoch-Shönlein purpura (HSP) is an immunoglobulin A (IgA) vasculitis impacting small blood vessels.
It presents as a multi-system disease with characteristic cutaneous purpura, arthralgia, enteritis, and nephritis, the latter marked by mesangial proliferation and IgA deposition.

Purpose of the Study:

To summarize the key features, pathogenesis, clinical manifestations, and outcomes of Henoch-Shönlein purpura.
To highlight the differences in disease presentation and prognosis between pediatric and adult populations.
To discuss current management strategies and the controversies surrounding treatment efficacy.

Main Methods:

Literature review and synthesis of existing research on Henoch-Shönlein purpura.
Analysis of clinical data regarding disease progression, complications, and treatment responses.

More Related Videos

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature

Published on: April 1, 2014

Related Experiment Videos

Last Updated: Jun 24, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature

Published on: April 1, 2014

Comparative evaluation of HSP in children versus adults.

Main Results:

HSP pathogenesis involves IgA, with nephritis being a common and serious complication.
While generally favorable in children, HSP in adults is rarer and associated with more severe outcomes.
Gastrointestinal and renal involvement significantly influence short-term and long-term prognoses, respectively, with up to one-third progressing to end-stage renal failure.

Conclusions:

HSP is an IgA-mediated vasculitis with variable severity and prognosis depending on age and organ involvement.
Renal and gastrointestinal complications are critical determinants of patient outcomes.
Management ranges from symptomatic treatment for mild cases to immunosuppressants for severe manifestations, though treatment efficacy remains debated.